Cipla

Cipla is a prominent pharmaceutical company based in Mumbai, India. Founded in 1935 by Khawaja Abdul Hamied, the company is known for its significant contributions to the Indian pharmaceutical industry and healthcare sector.

History[edit | edit source]

Khawaja Abdul Hamied established Cipla in 1935 during the British colonial era. The company's initial objective was to make India self-sufficient in healthcare. Over the years, Cipla has expanded its operations across 80 countries, providing over 1500 products in various therapeutic categories.

Products and Services[edit | edit source]

Cipla offers a wide range of products in key therapeutic areas including antiretroviral, cardiology, diabetes, neurology, and psychiatry. The company also provides services in clinical research, drug discovery, and biotechnology.

Achievements[edit | edit source]

Cipla has made significant contributions to the global fight against HIV/AIDS. In 2001, the company offered antiretroviral drugs at a fraction of the global prices, making treatment accessible to millions of people in developing countries.

Criticism[edit | edit source]

Despite its achievements, Cipla has faced criticism for its aggressive marketing strategies and for allegedly violating intellectual property rights.